Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013

Clinical Infectious Diseases

Volumn 60, Issue 9, 2015, Pages 1346-1356

  Von Mollendorf, Claire ^a,b   Von Gottberg, Anne ^a,c   Tempia, Stefano ^a,d   Meiring, Susan ^a   De Gouveia, Linda ^a   Quan, Vanessa ^a   Lengana, Sarona ^a   Avenant, Theunis ^e   Du Plessis, Nicolette ^e   Eley, Brian ^f   Finlayson, Heather ^g   Reubenson, Gary ^h   Moshe, Mamokgethi ⁱ   O'Brien, Katherine L ^j   Klugman, Keith P ^k,l   Whitney, Cynthia G ^m   Cohen, Cheryl ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b Faculty of Health Sciences   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF PRETORIA   (South Africa)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g STELLENBOSCH UNIVERSITY   (South Africa)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^k EMORY UNIVERSITY   (United States)

^l EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

more..

Author keywords

Children; HIV exposure; Pneumococcal conjugate vaccine; South Africa; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DYING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INFANT MORTALITY; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RACE DIFFERENCE; SEROPREVALENCE; SOUTH AFRICA; VERTICAL TRANSMISSION; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HIV INFECTIONS; MALE; MICROBIOLOGY; MORTALITY; NEWBORN; PNEUMOCOCCAL INFECTIONS; REGRESSION ANALYSIS; RISK FACTOR; TIME FACTOR; VIROLOGY;

CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; REGRESSION ANALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOUTH AFRICA; TIME FACTORS;

EID: 84928902809     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ059     Document Type: Article

References (40)

1. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ 2013; 91:70-4.
2. Massyn N, Day C, Dombo M, Barron P, English R, Padarath A. District health barometer 2012/13. Durban, South Africa: Health Systems Trust, 2013.
3. Slogrove A, Reikie B, Naidoo S, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012; 58:505-8.
4. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007; 369:1440-51.
5. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 2007; 119:e694-704.
6. Preidis GA, McCollum ED, Mwansambo C, Kazembe PN, Schutze GE, Kline MW. Pneumonia and malnutrition are highly predictive of mortality among African children hospitalized with human immunodeficiency virus infection or exposure in the era of antiretroviral therapy. J Pediatr 2011; 159:484-9.
7. Chilongozi D, Wang L, Brown L, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfect-ed pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J 2008; 27:808-14.
8. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-26.
9. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics 1999; 104:e56.
10. Sutcliffe CG, Scott S, Mugala N, et al. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis 2008; 47:837-44.
11. Venkatesh KK, Lurie MN, Triche EW, et al. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics. Trop Med Int Health 2010; 15:1364-74.
12. Taron-Brocard C, Le Chenadec J, Faye A, et al. Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country. Clin Infect Dis 2014; 59:1332-45.
13. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902.
14. Johnson LF. THEMBISA version 1.0: A model for evaluating the impact of HIV/AIDS in South Africa. Cape Town, South Africa: University of Cape Town Centre for Infectious Disease Epidemiology and Research. Available at: http://www.publichealth.uct.ac.za/sites/default/files/image-tool/images/108/THEMBISA%20version%201.0.pdf. Accessed 29 October 2014.
15. von Gottberg A, de Gouveia L, Tempia S, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 2014; 371:1889-99.
16. Cohen C, von Mollendorf C, de Gouveia L, et al. Effectiveness of 7-val-ent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and-uninfected children in South Africa: a matched case-control study. Clin Infect Dis 2014; 59:808-18.
17. Reikie BA, Naidoo S, Ruck CE, et al. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol 2013; 20:33-8.
18. Madhi SA, Adrian P, Cotton MF, et al. Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis 2010; 202:355-61.
19. Massyn N, Day C, Barron P, Haynes R, English R, Padarath A. District Health barometer 2011/12. Durban, South Africa: Health Systems Trust, 2013.
20. Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006. Pediatr Infect Dis J 2008; 27: 886-91.
21. Nunes MC, von Gottberg A, De Gouveia L, et al. The impact of an-tiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS 2011; 25:453-62.
22. Isanaka S, Duggan C, Fawzi WW. Patterns of postnatal growth in HIV-infected and HIV-exposed children. Nutr Rev 2009; 67:343-59.
23. Powis KM, Smeaton L, Ogwu A, et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr 2011; 56:131-8.
24. Nyasulu P, Cohen C, De Gouveia L, Feldman C, Klugman KP, von Gottberg A. Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005. Pediatr Infect Dis J 2011; 30:1075-80.
25. Madhi SA, Izu A, Violari A, et al. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and-uninfected infants. Vaccine 2013; 31:777-83.
26. Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seropreva-lence. Clin Infect Dis 1999; 29:321-7.
27. Crewe-Brown HH, Karstaedt AS, Saunders GL, et al. Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis 1997; 25:1165-72.
28. Soeters HM, von Gottberg A, Cohen C, Quan V, Klugman KP. Trimeth-oprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease. Antimicrob Agents Chemother 2012; 56:1602-5.
29. Nakiyingi JS, Bracher M, Whitworth JA, et al. Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study. AIDS 2003; 17:1827-34.
30. Ng'weshemi J, Urassa M, Isingo R, et al. HIV impact on mother and child mortality in rural Tanzania. J Acquir Immune Defic Syndr 2003; 33:393-404.
31. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236-43.
32. Afran L, Garcia KM, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol 2014; 176:11-22.
33. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009; 30:189-209.
34. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16:217-25.
35. van Hoek AJ, Andrews N, Waight PA, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012; 65:17-24.
36. De Moraes-Pinto MI, Almeida AC, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173:1077-84.
37. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4:358-61.
38. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol 2008; 126:243-50.
39. Nielsen SD, Jeppesen DL, Kolte L, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
40. Fox MP, Brooks DR, Kuhn L, et al. Role of breastfeeding cessation in mediating the relationship between maternal HIV disease stage and increased child mortality among HIV-exposed uninfected children. Int J Epidemiol 2009; 38:569-76.